Retatrutide works similarly to tirzepatide in some ways, but it adds an additional metabolic target
Muscle Tissue Changes with Aging. Current Opinion in Clinical Nutrition and Metabolic Care , vol
The current fervor for GLP-1RAs in the capital markets as well as in the general public, especially in terms of weight reduction, is probably going to result in overuse, said Chun-Su Yuan, MD, PhD, the Cyrus Tang Professor of Anesthesia and Critical Care at the University of Chicago
Are PlexusDx medications FDA-approved
Theoretically yes
High gastrointestinal discontinuation rates exceeding 50% across all doses, combined with liver safety signals in early studies, ultimately led Pfizer to discontinue danugliprons development in April 2025